Literature DB >> 9647217

Characterization of human fibroleukin, a fibrinogen-like protein secreted by T lymphocytes.

S Marazzi1, S Blum, R Hartmann, D Gundersen, M Schreyer, S Argraves, V von Fliedner, R Pytela, C Rüegg.   

Abstract

We have recently cloned the human homologue of the murine pT49 cDNA (hpT49h), a transcript encoding a protein homologous to the beta- and gamma-chains of fibrinogen. Here, we report the identification of the hpT49h gene product using mAbs generated against a peptide corresponding to the carboxyl-terminal end of the deduced protein and a recombinant protein fragment expressed in Escherichia coli. mAbs 23A6, 7B12, and 3F4 specifically recognized a protein of 70 kDa in reducing SDS-PAGE in the culture supernatant of 293T cells transiently transfected with the full length hpT49h cDNA and freshly isolated PBMC. Under nonreducing conditions, the material migrated with a molecular mass of 250 to 300 kDa, indicating that the 70-kDa protein forms a disulfide bonded complex. Because of its homology with fibrinogen, we have termed this protein fibroleukin. Fibroleukin is spontaneously secreted in vitro by freshly isolated CD4+ and CD8+ T lymphocytes. RT-PCR analysis revealed preferential expression of fibroleukin mRNA in memory T lymphocytes (CD3+/CD45R0+) compared with naive T lymphocytes (CD3+/CD45RA+). Fibroleukin production by PBMC was rapidly lost in culture. Production could be partially maintained in the presence of IFN-gamma, while T lymphocyte activation had no effect. To demonstrate fibroleukin production in vivo, we analyzed colon mucosa by immunohistology. Fibroleukin staining was detected in the extracellular matrix of the T lymphocyte-rich upper portion of the lamina propria mucosa. While the exact function of fibroleukin remains to be defined, these data suggest that fibroleukin may play a role in physiologic lymphocyte functions at mucosal sites.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9647217

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  40 in total

Review 1.  The Duality of Fgl2 - Secreted Immune Checkpoint Regulator Versus Membrane-Associated Procoagulant: Therapeutic Potential and Implications.

Authors:  Jiemiao Hu; Jun Yan; Ganesh Rao; Khatri Latha; Willem W Overwijk; Amy B Heimberger; Shulin Li
Journal:  Int Rev Immunol       Date:  2014-09-26       Impact factor: 5.311

2.  Fibrinogen-related protein, FGL2, of hamster cauda epididymal fluid: Purification, kinetic analysis of its prothrombinase activity, and its role in segregation of nonviable spermatozoa.

Authors:  Subir K Nagdas; Shamar Wallace; Don Eaford; Rashad Baker; Ky'ara Carr; Samir S Raychoudhuri
Journal:  Mol Reprod Dev       Date:  2020-11-20       Impact factor: 2.609

3.  Identification of the receptor for FGL2 and implications for susceptibility to mouse hepatitis virus (MHV-3)-induced fulminant hepatitis.

Authors:  Hao Liu; Li Zhang; Myron Cybulsky; Reg Gorczynski; Jennifer Crookshank; Justin Manuel; David Grant; Gary Levy
Journal:  Adv Exp Med Biol       Date:  2006       Impact factor: 2.622

4.  Feline leukemia virus DNA vaccine efficacy is enhanced by coadministration with interleukin-12 (IL-12) and IL-18 expression vectors.

Authors:  L Hanlon; D Argyle; D Bain; L Nicolson; S Dunham; M C Golder; M McDonald; C McGillivray; O Jarrett; J C Neil; D E Onions
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

5.  Von Willebrand factor protects against acute CCl4-induced hepatotoxicity through phospho-p38 MAPK signaling pathway inhibition.

Authors:  Hai-Jian Sun; Jian Chen; Hao Zhang; Bing Ni; Jennifer C van Velkinburgh; Yao Liu; Yu-Zhang Wu; Xia Yang
Journal:  Immunol Res       Date:  2017-10       Impact factor: 2.829

6.  The Fgl2/fibroleukin prothrombinase contributes to immunologically mediated thrombosis in experimental and human viral hepatitis.

Authors:  Philip A Marsden; Qin Ning; Laisum S Fung; Xioping Luo; Yue Chen; Michael Mendicino; Anand Ghanekar; Jeremy A Scott; Teresa Miller; Camie W Y Chan; Mathew W C Chan; Wei He; Reginald M Gorczynski; David R Grant; David A Clark; M James Phillips; Gary A Levy
Journal:  J Clin Invest       Date:  2003-07       Impact factor: 14.808

7.  Intact type 1 immunity and immune-associated coagulative responses in mice lacking IFN gamma-inducible fibrinogen-like protein 2.

Authors:  Wayne W Hancock; Frank M Szaba; Kiera N Berggren; Michelle A Parent; Isis K Mullarky; John Pearl; Andrea M Cooper; Kenneth H Ely; David L Woodland; In-Jeong Kim; Marcia A Blackman; Lawrence L Johnson; Stephen T Smiley
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-19       Impact factor: 11.205

8.  The regulatory T cell effector molecule fibrinogen-like protein 2 is necessary for the development of rapamycin-induced tolerance to fully MHC-mismatched murine cardiac allografts.

Authors:  Peter Urbanellis; Wendy Shyu; Ramzi Khattar; Jihong Wang; Anna Zakharova; Wei He; Hassan Sadozai; Achiya Z Amir; Itay Shalev; M James Phillips; Oyedele Adeyi; Heather Ross; David Grant; Gary A Levy; Andrzej Chruscinski
Journal:  Immunology       Date:  2015-01       Impact factor: 7.397

9.  Inhibitory function of Tregs via soluble FGL2 in chronic hepatitis B.

Authors:  Li Xu; Daofeng Yang; Yanlin Liu; Di Wu; Xiaojing Wang; Qin Ning
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2012-08-11

10.  Increased circulating fibrinogen-like protein 2 in patients with systemic sclerosis.

Authors:  Koichi Yanaba; Yoshihide Asano; Shinji Noda; Kaname Akamata; Naohiko Aozasa; Takashi Taniguchi; Takehiro Takahashi; Yohei Ichimura; Tetsuo Toyama; Hayakazu Sumida; Yoshihiro Kuwano; Yayoi Tada; Makoto Sugaya; Takafumi Kadono; Shinichi Sato
Journal:  Clin Rheumatol       Date:  2012-09-16       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.